Physiological properties of blood substitutes

News in Physiological Sciences

Volumn 16, Issue 1, 2001, Pages 38-41

  Spahn, Donat R ^a   Pasch, Thomas ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; OXYGEN;

ANIMAL; HUMAN; METABOLISM; REVIEW;

ANIMALS; BLOOD SUBSTITUTES; HUMANS; OXYGEN;

EID: 0035257785     PISSN: 08861714     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiologyonline.2001.16.1.38     Document Type: Article

References (15)

1. DeAngeles DA, Scott AM, McGrath AM, Korent VA, Rodenkirch LA, Conhaim RL, and Harms BA. Resuscitation from hemorrhagic shock with diaspirin cross-linked hemoglobin, blood, or hetastarch. J Trauma 42: 406-412, 1997.
2. Gould SA, Moore EE, Hoyt DB, Burch JM, Haenel JB, Garcia J, DeWoskin R, and Moss GS. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 187: 113-120, 1998.
3. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, and Yetisir E. Transfusion requirements in critical care investigators for the Canadian critical care trials group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340: 409-417, 1999.
4. Keipert PE. Perfluorochemical emulsions: future alternatives to transfusion. Blood Subst Princ Meth Prod Clin Trials 2: 127-156, 1998.
5. Lamy ML, Daily EK, Brichant J-F, Larbuisson RP, Demeyer RH, Vandermeersch EA, Lehot J-J, Parsloe MR, Berridge JC, Sinclair CJ, Baron J-F, and Przybelski RJ. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. Anesthesiology 92: 646-656, 2000.
6. Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, and Rodman G. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 282: 1857-1864, 1999.
7. Spahn DR. Blood substitutes: artificial oxygen carriers: perfluorocarbon emulsions. Crit Care 3: R93-R97, 1999.
8. Spahn DR and Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 93: 242-255, 2000.
9. Spahn DR, Leone BJ, Reves JC, and Pasch T. Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 78: 1000-1021, 1994.
10. Spahn DR, van Bremt R, Theilmeier G, Reibold JP, Welte M, Heinzerling H, Birck K, Keipert PE, and Messmer K. Perflubron emulsion delays blood transfusion in orthopedic surgery. Anesthesiology 91: 1195-1208, 1999.
11. Viele MK, Weiskopf RB, and Fisher D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology 86: 848-858, 1997.
12. Vlahakes GJ, Lee R, Jacobs EE, LaRaia PJ, and Austen WG. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 100: 379-388, 1990.
13. Wahr JA, Trouwborst A, Spence RK, Henny CP, Cernaianu AC, Graziano GP, Tremper KK, Flaim KE, Keipert PE, Faithfull NS, and Clymer JJ. A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth Analg 82: 103-107, 1996.
14. Winslow RM. Blood substitutes. Adv Drug Del Rev 40: 131-142, 2000.
15. Xu L, Sun L, Rollwagen FM, Li Y, Pacheco ND, Pikoulis E, Leppaniemi A, Soltero R, Burris D, Malcolm D, and Nielsen TB. Cellular responses to surgical trauma, hemorrhage, and resuscitation with diaspirin cross-linked hemoglobin in rats. J Trauma 42: 32-41, 1997.